Catherine Ferrer

Université de Nîmes

Papers

2

Total Citations

36

H-Index

2

About

Catherine Ferrer is a leading gynecologic oncologist whose research focuses on optimizing surgical outcomes through minimally invasive techniques, particularly in the context of complex cancer care. Her most impactful work stems from the landmark ROBOGYN-1004 trial, which rigorously compared robot-assisted laparoscopy (RL) to conventional laparoscopy (CL) in gynecologic oncology. Her seminal 2020 paper, which has garnered 34 citations, provided critical evidence on severe perioperative morbidity, demonstrating that while both approaches are viable, patient and procedural factors significantly influence complication rates. In a subsequent 2024 secondary analysis of the same trial, Ferrer further clarified how surgical complexity and institutional experience directly impact postoperative morbidity, offering actionable insights for improving patient safety. By systematically dissecting the nuances of surgical risk, Ferrer has helped shape evidence-based guidelines for the adoption of robotic surgery, ensuring that technological advancements translate into tangible benefits for women with gynecologic cancers. Her work underscores a commitment to rigorous, patient-centered research that bridges the gap between innovation and clinical reality.

Research Focus

Key Achievements

2
H-Index
2
Papers
36
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Severe perioperative morbidity after robot-assisted versus conventional laparoscopy in gynecologic oncology: Results of the randomized ROBOGYN-1004 trial
34 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Université de Nîmes

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago